TuisBMYB34 • BVMF
add
Bristol-Myers Squibb Company BDR
Vorige sluiting
R$334,77
Jaarwisseling
R$197,88 - R$361,00
Markkapitalisasie
113,07Â mjd USD
Gemiddelde volume
132,00
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 11,89Â mjd | 8,44% |
Bedryfskoste | 6,84Â mjd | 7,33% |
Netto inkomste | 1,21Â mjd | -37,19% |
Netto winsgrens | 10,18 | -42,09% |
Wins per aandeel | 1,80 | -10,00% |
EBITDA | 4,83Â mjd | 5,53% |
Effektiewe belastingkoers | 27,51% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 8,09Â mjd | 5,32% |
Totale bates | 93,67Â mjd | 2,64% |
Totale aanspreeklikheid | 76,47Â mjd | 22,94% |
Totale ekwiteit | 17,20 mjd | — |
Uitstaande aandele | 2,03 mjd | — |
Prys om te bespreek | 39,62 | — |
Opbrengs op bates | 5,83% | — |
Opbrengs op kapitaal | 7,86% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 1,21Â mjd | -37,19% |
Kontant van bedrywe | 5,59Â mjd | 17,68% |
Kontant van beleggings | -219,00Â m | 46,59% |
Kontant van finansiering | -3,85Â mjd | 25,35% |
Netto kontantverandering | 1,60Â mjd | 286,35% |
Beskikbare kontantvloei | 5,59Â mjd | 51,71% |
Meer oor
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
BMS's primary research and development sites are located in Lawrence, New Jersey, Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts, Braine-l'Alleud, Belgium, Tokyo, Japan, Hyderabad; Bangalore, India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut. Wikipedia
Gestig
1887
Webwerf
Werknemers
34Â 100